Jump to content

User:Swunalightyear/sandbox: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
clear sandbox
Tag: Replaced
Line 1: Line 1:
{{User sandbox}}
{{User sandbox}}
<!-- EDIT BELOW THIS LINE -->
<!-- EDIT BELOW THIS LINE -->The '''South Carolina opioid overdose prevention bill''' is legislation sponsored in the South Carolina state legislature (House of Representatives). The bill, numbered SC H.B. 4711 and sponsored by state Representative Russell Fry, would require prescribers to offer a prescription for naloxone (or other equivalent opioid overdose medication) to patients at high risk of an opioid overdose.


== Background ==
Beginning in the 1990s the United States experienced an [[Opioid epidemic in the United States|opiate abuse and addiction epidemic]], initially set in motion by the over-prescribing of opioid pain medication by physicians. Between 1999 and 2017, more than 399,000 people died from drug overdoses that involved either prescription or illicit opiate drugs.<ref>{{Cite journal|last=Scholl|first=Lawrence|last2=Seth|first2=Puja|last3=Kariisa|first3=Mbabazi|last4=Wilson|first4=Nana|last5=Baldwin|first5=Grant|date=2018-12-21|title=Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017|url=http://www.cdc.gov/mmwr/volumes/67/wr/mm675152e1.htm?s_cid=mm675152e1_w|journal=MMWR. Morbidity and Mortality Weekly Report|volume=67|issue=5152|doi=10.15585/mmwr.mm675152e1|issn=0149-2195}}</ref>

[[Naloxone]] is a prescription medication that reverses the effects of an opioid overdose, often in seconds. An opioid overdose halts breathing, which is why overdoses are often fatal. The administration of naloxone via nasal spray or direct injection can quickly restart breathing in an overdose victim.<ref>{{Cite web|last=Abuse|first=National Institute on Drug|date=2020-02-20|title=Opioid Overdose Reversal with Naloxone (Narcan, Evzio)|url=https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-reversal-naloxone-narcan-evzio|access-date=2020-07-09|website=National Institute on Drug Abuse|language=en}}</ref>

In 2018, there were 835 opioid overdose deaths in South Carolina, an increase from 2016 which saw 628 deaths. Overall in the U.S. in 2018, there were 67,367 overdose deaths involving opioid drugs, a 4.1% decline nationwide from 2017.<ref name=":1">{{Cite web|last=Abuse|first=National Institute on Drug|date=2020-04-03|title=South Carolina: Opioid-Involved Deaths and Related Harms|url=https://www.drugabuse.gov/drug-topics/opioids/opioid-summaries-by-state/south-carolina-opioid-involved-deaths-related-harms|access-date=2020-07-09|website=National Institute on Drug Abuse|language=en}}</ref> According to the National Institute on Drug Abuse, “Deaths involving synthetic opioids other than methadone (mainly [[fentanyl]] and fentanyl analogs) continued to rise from 404 (8.5 per thousand) in 2017 to 510 (10.8/thousand) in 2018.”<ref name=":1" />

== Legislation ==
The bill requires medical practitioners to offer a prescription for naloxone (or equivalent) to certain at-risk patients. Specifically, physicians and other prescribers shall “offer a prescription for a drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.”<ref name=":0">{{Cite web|title=2019-2020 Bill 4711 Text of Previous Version (Feb. 20, 2020) - South Carolina Legislature Online|url=https://www.scstatehouse.gov/sess123_2019-2020/prever/4711_20200220.htm|access-date=2020-07-09|website=www.scstatehouse.gov}}</ref>

At-risk patients are defined as patients who fit any of the following criteria:<ref name=":0" />

* Are currently prescribed 90 or more morphine milligram equivalents of an opioid medication per day; or
* Have a concurrent prescription for a benzodiazepine drug; or
* Have an increased risk of overdose, defined as “a patient with a history of overdose, a patient with a history of substance use disorder, or a patient at risk for returning to a high dose of opioid medication to which the patient is no longer tolerant.”

The legislation also requires the prescriber to provide patient education about opioid overdose.<ref name=":0" />

== Legislative action ==
The legislation was introduced in the [[South Carolina House of Representatives]] on January 14, 2020 by state Representative [[Russell Fry]]. On February 20, 2020, the Committee on Medical, Military, Public and Municipal Affairs passed the bill. Debate in the full state House is pending as of March 3, 2020.<ref>{{Cite web|title=2019-2020 Bill 4711: Naloxone - South Carolina Legislature Online|url=https://www.scstatehouse.gov/sess123_2019-2020/bills/4711.htm|access-date=2020-07-09|website=www.scstatehouse.gov}}</ref>

As of July 1, 2020, the bill had 25 cosponsors.<ref>“[https://www.quorum.us/bill/2646020/ SC H.B.4711: Naloxone].” Quorum. Subscription required. Retrieved 2020-07-01.</ref>


== See also ==
== See also ==
Line 30: Line 8:
* [[New Jersey Opioid Antidote Prescription Bill]]
* [[New Jersey Opioid Antidote Prescription Bill]]
* [[New York Mandatory Opioid Antagonist Prescription Bill]]
* [[New York Mandatory Opioid Antagonist Prescription Bill]]
* [[South Carolina Opioid Overdose Prevention Bill]]


==References==
==References==
{{Reflist}}
{{Reflist}}

==External links==

* “[https://www.scdhec.gov/opioid-epidemic Opioid Epidemic],” [[South Carolina Department of Health and Environmental Control]], Bureaus of Drug Control
* “[https://www.daodas.sc.gov/wp-content/uploads/2018/08/Opioid-Mortality.pdf Opioid Mortality and Selected Trends: 2017 South Carolina Overdose Mortality Data],” South Carolina Department of Alcohol and Other Drug Abuse Services

Revision as of 16:19, 22 July 2020


See also

References